Determination of everolimus in whole blood using the Abbott IMx® sirolimus microparticle enzyme immunoassay

Clinical Biochemistry

Volumn 40, Issue 1-2, 2007, Pages 132-136

  Bouzas, Lorena ^a   Tutor, J Carlos ^a  

^a Instituto de Salud Carlos III   (Spain)

Author keywords

Everolimus; Fluorescence polarization immunoassay; Microparticle enzyme immunoassay

Indexed keywords

EVEROLIMUS; RAPAMYCIN;

ARTICLE; BLOOD; BLOOD SAMPLING; CALIBRATOR; CLINICAL ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CROSS REACTION; DRUG DETERMINATION; FLUORESCENCE POLARIZATION IMMUNOASSAY; HEMATOCRIT; HUMAN; KIDNEY GRAFT; LINEAR REGRESSION ANALYSIS; MICROPARTICLE ENZYME IMMUNOASSAY; PRIORITY JOURNAL;

CROSS REACTIONS; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMANS; IMMUNOENZYME TECHNIQUES; REAGENT KITS, DIAGNOSTIC; REGRESSION ANALYSIS; SIROLIMUS;

EID: 33845783865     PISSN: 00099120     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2006.08.005     Document Type: Article

References (13)

1. Kirchner G.I., Meier-Wiedenbach I., and Manns M.P. Clinical pharmacokinetics of everolimus. Clin. Pharmacokinet. 43 (2004) 83-95
2. Crowe A., Bruelisauer A., Druerr L., et al. Absorption and intestinal metabolism of SDZ-RAD and rapamycin in rats. Drug Metab. Dispos. 27 (1999) 627-632
3. Mahalati K., and Kahan B.D. Clinical pharmacokinetics of sirolimus. Clin. Pharmacokinet. 40 (2001) 573-585
4. Mabasa V.H., and Ensom M.H.H. The role of therapeutic monitoring of everolimus in solid organ transplantation. Ther. Drug Monit. 27 (2005) 666-676
5. Engelmayer J., Engelmayer U., Streit F., et al. Comparison of the Seradyn Innofluor® Certican® assay on the TDxFLx® system with LC/MS-MS [abstract]. Ther. Drug Monit. 27 (2005) 217
6. Johnson R.N., Sargon R., Woollard G., and Davidson J. An evaluation of the IMx sirolimus assay in relation to a high-performance liquid chromatography-ultraviolet method. Ann. Clin. Biochem. 42 (2005) 394-397
7. Wilson D., Johnston F., Holt D., et al. Multi-center evaluation of analytical performance of the microparticle enzyme immunoassay for sirolimus. Clin. Biochem. 39 (2006) 378-386
8. Eksborg S. Evaluation of method-comparison data. Clin. Chem. 27 (1981) 1311-1312
9. Knoll E., Hafner F., Dettmer K., and Wisser H. The determination of calcium, glucose, urea and uric acid using the Kodak Ektachem multiplayer technology: an evaluation. J. Clin. Chem. Clin. Biochem. 20 (1982) 491-498
10. Harris E.K. Proposed goals for analytical precision and accuracy in single-point diagnostic testing. Arch. Pathol. Lab. Med. 112 (1988) 416-420
11. Shah V.P., Midha K.K., Dighe S., et al. Analytical methods evaluation: bioavailability, bioequivalence and pharmacokinetic studies. Eur. J. Drug Metab. Pharmacokinet. 16 (1991) 249-255
12. Strom T., Boyd J., Arabshahi L., Marbach P., and Christians U. Cross-reactivity of the major everolimus hydroxy metabolites with the Innofluor® Certican® immunoassay for clinical Tdm of everolimus [abstract]. Ther. Drug Monit. 27 (2005) 243
13. Salm P., Warnholtz C., Boyd J., Arabshani L., Marbach P., and Taylor P.J. Evaluation of a fluorescent polarization immunoassay for whole blood everolimus determination using samples from renal transplant recipients. Clin. Biochem. 39 (2006) 732-738